SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
MARBUT BOB

(Last) (First) (Middle)
200 CONCORD PLAZA, SUITE 700

(Street)
SAN ANTONIO TX 78216

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/24/2006
3. Issuer Name and Ticker or Trading Symbol
Argyle Security Acquisition CORP [ OTCBB-__ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Co-Chief Executive Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 90,607 I By Argyle Joint Venture(1)
Common Stock 273,437 I By Argyle New Ventures, L.P.(2)
Common Stock 93,750(3) I By Argyle New Ventures, L.P.(2)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (4) 03/13/2006 Common Stock 13,125 $0.027 I By Argyle Joint Venture(1)
Stock Option (Right to Buy) (4) 03/13/2006 Common Stock 39,649 $0.027 I By Argyle New Ventures, L.P.(2)
Warrant (Right to Buy) (5) 01/24/2011 Common Stock 93,750(3) $5.5 I By Argyle New Ventures, L.P.(2)
Explanation of Responses:
1. Mr. Marbut has voting and dispositive power over the shares held by Argyle Joint Venture. Although Argyle Joint Venture owns 273,438 shares and options to purchase 39,648 shares, Mr. Marbut has a pecuniary interest in only 90,607 of such shares and 13,125 of such options to purchase shares.
2. Mr. Marbut owns the general partner of Argyle New Ventures, L.P.
3. The reported securities are included within 93,750 units purchased by Argyle New Ventures, L.P. for $8.00 per unit in a private placement. Each unit consists of one share of common stock and one warrant to purchase common stock.
4. The options are only exercisable in the event that the underwriters in the initial public offering of Argyle Security Acquisition Corporation exercise their over-allotment option, and then only to the extent necessary to maintain the percentage ownership of the applicable stockholder's percentage ownership of Argyle Security Acquisition Corporation after taking into account the exercise of the over-allotment option. After the exercise of the over-allotment option by the underwriters, the applicable stockholder will have three business days to exercise such stockholder's option.
5. The warrants will become exercisable on the later of (i) the completion by the issuer of a business combination with a target company and (ii) 1/24/07.
/s/ Bob Marbut 01/24/2006
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.